Venus Medtech (Hangzhou) Inc. Stock

Equities

2500

CNE100003PJ8

Medical Equipment, Supplies & Distribution

Market Closed - Hong Kong S.E. 03:08:30 2023-11-22 am EST 5-day change 1st Jan Change
5.62 HKD -0.71% Intraday chart for Venus Medtech (Hangzhou) Inc. -.--% -.--%

Financials

Sales 2023 491M 67.9M 532M Sales 2024 * 787M 109M 853M Capitalization 2.26B 312M 2.45B
Net income 2023 -721M -99.63M -781M Net income 2024 * -274M -37.86M -297M EV / Sales 2023 4.6 x
Net cash position 2023 * 410M 56.6M 444M Net Debt 2024 * 125M 17.29M 136M EV / Sales 2024 * 3.03 x
P/E ratio 2023
-3.13 x
P/E ratio 2024 *
-8.42 x
Employees 865
Yield 2023 *
-
Yield 2024 *
-
Free-Float 73.87%
More Fundamentals * Assessed data
Dynamic Chart
1 day-0.71%
6 months+22.71%
More quotes
1 year
3.74
Extreme 3.74
12.66
3 years
3.74
Extreme 3.74
75.00
5 years
3.74
Extreme 3.74
97.00
10 years
3.74
Extreme 3.74
97.00
More quotes
Managers TitleAgeSince
Chief Executive Officer 50 16-11-30
Director of Finance/CFO 47 23-01-03
Director/Board Member 47 17-10-31
Members of the board TitleAgeSince
Chief Executive Officer 50 16-11-30
Chairman 69 18-11-25
Director/Board Member 41 18-11-25
More insiders
Venus MedTech (HangZhou) Inc. is a China-based company engaged in the research, development, manufacture and sales of minimally invasive medical devices and auxiliary instruments and equipment for the treatment of heart valve diseases. The Company's main products include the VenusA-Valve System, VenusA-Plus System, VenusA-Pilot System, VenusP-Valve System, TMVR valve, TTVR valve, valvuloplasty balloons V8 / TAV8 and TriGUARD3 Cerebral Embolic Protection Device.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
5
Last Close Price
5.157 CNY
Average target price
7.988 CNY
Spread / Average Target
+54.90%
Consensus